Literature DB >> 28390591

Author's response.

William D Johnson1.   

Abstract

Entities:  

Mesh:

Year:  2017        PMID: 28390591      PMCID: PMC5497838          DOI: 10.1016/j.anai.2017.02.009

Source DB:  PubMed          Journal:  Ann Allergy Asthma Immunol        ISSN: 1081-1206            Impact factor:   6.347


× No keyword cloud information.
  2 in total

1.  Angioedema in the omalizumab chronic idiopathic and spontaneous urticarial pivotal studies: Clinical relevance vs statistical significance.

Authors:  William D Johnson
Journal:  Ann Allergy Asthma Immunol       Date:  2016-10       Impact factor: 6.347

2.  Angioedema in the omalizumab chronic idiopathic/spontaneous urticaria pivotal studies.

Authors:  James L Zazzali; Allen Kaplan; Marcus Maurer; Karina Raimundo; Benjamin Trzaskoma; Paul G Solari; Evgeniya Antonova; Meryl Mendelson; Karin E Rosén
Journal:  Ann Allergy Asthma Immunol       Date:  2016-07-14       Impact factor: 6.347

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.